Federal Member for Page Kevin Hogan has announced that thousands of Australians living with breast cancer, lung cancer, osteoporosis and asthma will benefit from new and amended medicines listings on the Pharmaceutical Benefits Scheme (PBS). From 1 April, Kisqali® (ribociclib) is having its listing expanded on the PBS to be used in combination with…
Thousands of Australians with multiple sclerosis, asthma and diabetes will benefit from the listing or extension of several medications on the Pharmaceutical Benefits Scheme (PBS). Federal Member for Page Kevin Hogan said this is bringing further support to patients and their families. From March 1, Zeposia® and Atecture Breezhaler® was listed on the…
Australians with a rare, fatal heart condition will soon have subsidised access to a ground-breaking medicine for the first time, thanks to its new listing on the Pharmaceutical Benefits Scheme (PBS). Federal Member for Page Kevin Hogan said from today Uptravi® (selexipag) will be PBS listed for the first time to treat Pulmonary Arterial…
Australian adults living with Attention Deficit Hyperactivity Disorder (ADHD) will soon have more affordable access to a life-changing treatment option, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS). Federal Member for Page Kevin Hogan said from today the Government is expanding the listing of Vyvanse® (lisdexamfetamine) to include patients who are…
Cheaper medicine is avaliable for more than 500,000 patients, with price reductions for common scripts and new medicines added to the Pharmaceutical Benefits Scheme (PBS), the Federal Member for Page Kevin Hogan said. “In some cases this will save over $100,000 per patient,” “Medicines to treat lung cancer, lymphoblastic and acute leukaemia, and nausea associated…
The Government will invest $27 million to provide affordable access to three new medicines through the Pharmaceutical Benefits Scheme (PBS), helping Australians living with complications following stroke, fighting cancer, and experiencing syphilis in northern, central and southern Australia. The September 1 PBS listings will include amending the current listing for Opdivo® (Nivolumab) for the treatment…
Federal Member for Page Kevin Hogan said the Government will help improve the lives of those living with diabetes and hepatitis C by making two treatments more affordable, helping patients save thousands of dollars a year. He said hepatitis C drug Maviret is now listed on the Pharmaceutical Benefits Scheme (PBS). “Without the listing, patients…